A Phase II Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Capecitabine (Primary) ; Celecoxib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms ADAPT
- 10 Jun 2017 Biomarkers information updated
- 01 May 2017 Status changed from suspended to discontinued as Funding ended.
- 25 Mar 2016 Status changed from recruiting to suspended, according to ClinicalTrials.gov record.